← Back to headlines
Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
Evercore ISI projects long-term growth potential for BioCryst Pharmaceuticals, Inc. (BCRX) following its acquisition of Astria.
23 Feb, 21:42 — 23 Feb, 21:42
Sources
Showing 1 of 1 sources
Related Stories
SK Hynix Breaks Ground on $4 Billion Indiana HBM Packaging Plant
23m ago
TotalEnergies Finalizes Exit From Sanctioned Russian Arctic LNG 2 Project
30m ago
Nvidia Reports Strong Earnings, Prompting Analyst Upgrades and Tech Rally
1h ago
Canada Removes US Seafood From Retaliatory Tariff List Amid Trade Tensions
1h ago